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Fluoroscopy-guided foam sclerotherapy with
sodium morrhuate for peripheral venous
malformations: Preliminary experienceVenous malformations may be treated non-operatively
through sclerotherapy. The authors describe their experi-
ence with fluoroscopic guidance as compared to the more
often utilized ultrasound scan guidance, with promising
results.
Sclerotherapy involves instilling an agent into a vein
through percutaneous access. Foam sclerotherapy is a mi-
nor alteration in which air is mixed with the sclerosant and
then injected. There is no difference, from a coding per-
spective, between these two techniques. When injections
(single or multiple) are directed into spider veins on a limb
or the trunk, CPT code 36468 is appropriate. However, if
sclerotherapy is performed on facial telangiectasias, CPT
code 36469 is more fitting. These two descriptors generally
illustrate procedures that have been deemed “cosmetic”.
CPT code 36471 is reported when the practitioner at-
tempts to ablate multiple veins in one leg. Management of
bilateral leg pathology requires use of the 50 modifier.
Lastly, CPT code 35470 describes sclerotherapy in a single
vein without limitation based on anatomic location. Since
venous malformations are not usually classified as spider
veins, CPT code 36471 allows for lower extremity treat-
ments with multiple injections while CPT code 36470
covers a single vein injection in any anatomic bed. That
leaves multiple injections in the arms or face as illustrated in
this manuscript without a formal description. Therefore,
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1082therapy in these regions would be reported through the
unlisted vascular procedure CPT code 37799.
Ultrasound scan guidance to help ensure a needle
enters the appropriate vein for injection purposes can be
described by either CPT code 76937 or 76942. CPT code
76937 is defined as “ultrasound guidance for vascular
access requiring ultrasound scan evaluation of potential
access sites” whereas the descriptor for 76942 states “ultra-
sonic scan guidance for needle placement (eg, biopsy,
aspiration, injection, localization device)”. Since both are
applicable, either would be reasonable, provided a record of
the technique is permanently stored in the patient’s file. On
the other hand, if the ultrasound scan is used solely to
observe the foam sclerosant after injection, CPT code
93971 would describe a limited venous ultrasound scan in
an extremity.
Fluoroscopic guidance for needle placement is simply
reported by CPT code 77002. In this manuscript, however,
fluoroscopy is not used for direct needle placement. The
fluoroscopy allows the operator to follow the foam sclero-
sant after the injection to assess venous outflow. Non-
specific fluoroscopy is contained within CPT code 76000
for up to one hour of physician time. If the time commit-
ment was greater than 1 hour, CPT code 76001 is more
appropriate.
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